5 4 Jacob Medical Imaging Ltd 12049711 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is 86220 Digita Accounts Production Advanced 6.30.9574.0 true 12049711 2024-04-01 2025-03-31 12049711 2025-03-31 12049711 core:RetainedEarningsAccumulatedLosses 2025-03-31 12049711 core:ShareCapital 2025-03-31 12049711 core:CurrentFinancialInstruments 2025-03-31 12049711 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 12049711 core:Non-currentFinancialInstruments 2025-03-31 12049711 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 12049711 bus:SmallEntities 2024-04-01 2025-03-31 12049711 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12049711 bus:FilletedAccounts 2024-04-01 2025-03-31 12049711 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12049711 bus:RegisteredOffice 2024-04-01 2025-03-31 12049711 bus:Director1 2024-04-01 2025-03-31 12049711 bus:Director2 2024-04-01 2025-03-31 12049711 bus:Director3 2024-04-01 2025-03-31 12049711 bus:Director4 2024-04-01 2025-03-31 12049711 bus:Director5 2024-04-01 2025-03-31 12049711 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12049711 bus:Agent1 2024-04-01 2025-03-31 12049711 core:ComputerEquipment 2024-04-01 2025-03-31 12049711 core:Vehicles 2024-04-01 2025-03-31 12049711 countries:EnglandWales 2024-04-01 2025-03-31 12049711 2023-04-01 2024-03-31 12049711 2024-03-31 12049711 core:RetainedEarningsAccumulatedLosses 2024-03-31 12049711 core:ShareCapital 2024-03-31 12049711 core:CurrentFinancialInstruments 2024-03-31 12049711 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 12049711 core:Non-currentFinancialInstruments 2024-03-31 12049711 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 xbrli:pure iso4217:GBP

Registration number: 12049711

Jacob Medical Imaging Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Jacob Medical Imaging Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 6

Jacob Medical Imaging Ltd

Company Information

Directors | Dr Koshy Jacob Mrs Beulah Jacob Leah Jacob Michelle Jacob Naomi Ann Jacob

Registered office | 13 Durleigh Road Bridgwater Somerset TA6 7HU

Accountants | RiverView Portfolio Limited 1 Market Hill Calne Wiltshire SN11 0BT

Jacob Medical Imaging Ltd

(Registration number: 12049711)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets |  | 63,911 | 1,471
Current assets |  |  |
Debtors | 4 | 94,786 | 97,788
Cash at bank and in hand |  | 4,995 | 37,419
|  | 99,781 | 135,207
Creditors: Amounts falling due within one year | 5 | (75,018) | (64,268)
Net current assets |  | 24,763 | 70,939
Total assets less current liabilities |  | 88,674 | 72,410
Creditors: Amounts falling due after more than one year | 5 | (16,444) | -
Net assets |  | 72,230 | 72,410
Capital and reserves |  |  |
Called up share capital |  | 1 | 1
Retained earnings |  | 72,229 | 72,409
Shareholders' funds |  | 72,230 | 72,410

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 19 September 2025 and signed on its behalf by:

......................................... Dr Koshy Jacob Director

Jacob Medical Imaging Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
13 Durleigh Road
Bridgwater
Somerset
TA6 7HU
England

These financial statements were authorised for issue by the Board on 19 September 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Jacob Medical Imaging Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

2 | Accounting policies (continued)

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Computer Equipment | 25% Straight Line
Motor Vehicles | 25% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Jacob Medical Imaging Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

2 | Accounting policies (continued)

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 5 (2024 - 4).

4 | Debtors

Current | Note | 2025 £ | 2024 £
Trade debtors |  | 85,982 | 9,120
Amounts owed by related parties |  | - | 49,703
Prepayments |  | 8,804 | 31,663
Other debtors |  | - | 7,302
|  | 94,786 | 97,788

Jacob Medical Imaging Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025 (continued)

5 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 6 | 13,383 | -
Trade creditors |  | 2,896 | 32,494
Amounts owed to group undertakings and undertakings in which the company has a participating interest |  | 9,000 | 16,860
Taxation and social security |  | 45,616 | 13,024
Accruals and deferred income |  | 450 | 450
Other creditors |  | 3,673 | 1,440
|  | 75,018 | 64,268

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 6 | 16,444 | -

6 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Other borrowings | 16,444 | -